Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron plus simplified behavioral intervention for overactive bladder
ChiCTR2200058592Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mirabegron in overactive bladder (OAB) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Voiding diary, Overactive bladder symptom scale (OABSS) and 6 more. Planned start May 2022; status: not yet recruiting.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ChiCTR2200058592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058592.